Denmark reports two more 'serious' blood clot cases in connection with AstraZeneca jab
Danish authorities on Saturday reported a further two cases of cerebral thrombosis among hospital staff shortly after they received an inoculation with the AstraZeneca Covid-19 vaccine.
The cases were reported in the capital Copenhagen, with one resulting in a fatality, Reuters reported on Saturday.
Both people had received the AstraZeneca jab within 14 days of suffering blood clots.
Denmark has held off on restarting vaccinations with the British-Swedish company's jab, even after the European Medicines Agency declared it “safe and effective” on Thursday.
"Our decision to put vaccination with the Covid-19 vaccine from AstraZeneca on hold until week 12 (March 22-28) remains in effect," the head of the Danish Health Authority, Soren Brostrom, said in a statement late Thursday.
"In the coming days, the Danish Health Authority and the Danish Medicines Agency will assess the impact of EMA's review of the Covid-19 vaccine from AstraZeneca on the Danish vaccination programme," he added.
Last week, Denmark was the first country to suspend use of the AstraZeneca jab, a decision then followed by more than a dozen other mostly European countries.
Sweden and Norway have also said they will wait before resuming its use as they investigate further, while Iceland has yet to announce its decision.
Comments
See Also
The cases were reported in the capital Copenhagen, with one resulting in a fatality, Reuters reported on Saturday.
Both people had received the AstraZeneca jab within 14 days of suffering blood clots.
Denmark has held off on restarting vaccinations with the British-Swedish company's jab, even after the European Medicines Agency declared it “safe and effective” on Thursday.
"Our decision to put vaccination with the Covid-19 vaccine from AstraZeneca on hold until week 12 (March 22-28) remains in effect," the head of the Danish Health Authority, Soren Brostrom, said in a statement late Thursday.
"In the coming days, the Danish Health Authority and the Danish Medicines Agency will assess the impact of EMA's review of the Covid-19 vaccine from AstraZeneca on the Danish vaccination programme," he added.
Last week, Denmark was the first country to suspend use of the AstraZeneca jab, a decision then followed by more than a dozen other mostly European countries.
Sweden and Norway have also said they will wait before resuming its use as they investigate further, while Iceland has yet to announce its decision.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.